A detailed history of Strategic Global Advisors, LLC transactions in Novartis Ag stock. As of the latest transaction made, Strategic Global Advisors, LLC holds 11,891 shares of NVS stock, worth $1.17 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares
11,891
Previous 5,451 118.14%
Holding current value
$1.17 Million
Previous $580,000 135.69%
% of portfolio
0.27%
Previous 0.12%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$106.13 - $120.89 $683,477 - $778,531
6,440 Added 118.14%
11,891 $1.37 Million
Q2 2024

Aug 14, 2024

SELL
$92.57 - $107.37 $489,325 - $567,557
-5,286 Reduced 49.23%
5,451 $580,000
Q1 2024

May 15, 2024

SELL
$95.27 - $108.47 $9,812 - $11,172
-103 Reduced 0.95%
10,737 $1.04 Million
Q4 2023

Feb 14, 2024

SELL
$92.27 - $101.54 $23,067 - $25,385
-250 Reduced 2.25%
10,840 $1.09 Million
Q3 2023

Nov 14, 2023

SELL
$94.73 - $105.13 $71,615 - $79,478
-756 Reduced 6.38%
11,090 $1.13 Million
Q2 2023

Aug 14, 2023

SELL
$92.52 - $104.91 $21,649 - $24,548
-234 Reduced 1.94%
11,846 $1.2 Million
Q1 2023

May 15, 2023

BUY
$80.03 - $92.81 $613,269 - $711,203
7,663 Added 173.49%
12,080 $1.11 Million
Q4 2022

Feb 14, 2023

SELL
$75.55 - $92.52 $1,662 - $2,035
-22 Reduced 0.5%
4,417 $400,000
Q3 2022

Nov 14, 2022

BUY
$74.61 - $87.26 $15,145 - $17,713
203 Added 4.79%
4,439 $337,000
Q2 2022

Aug 15, 2022

SELL
$80.52 - $93.75 $5,233 - $6,093
-65 Reduced 1.51%
4,236 $358,000
Q1 2022

May 16, 2022

BUY
$80.11 - $90.62 $4,966 - $5,618
62 Added 1.46%
4,301 $377,000
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $1.35 Million - $1.49 Million
-16,912 Reduced 79.96%
4,239 $1.67 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $4,825 - $5,613
-59 Reduced 0.28%
21,151 $1.73 Million
Q2 2021

Aug 12, 2021

SELL
$85.24 - $94.15 $2.47 Million - $2.72 Million
-28,939 Reduced 57.71%
21,210 $1.94 Million
Q1 2021

May 14, 2021

BUY
$83.5 - $98.47 $10,437 - $12,308
125 Added 0.25%
50,149 $4.29 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $134,826 - $163,080
-1,727 Reduced 3.34%
50,024 $4.72 Million
Q3 2020

Nov 13, 2020

BUY
$82.14 - $91.0 $467,540 - $517,972
5,692 Added 12.36%
51,751 $4.5 Million
Q2 2020

Aug 13, 2020

BUY
$80.93 - $91.1 $895,247 - $1.01 Million
11,062 Added 31.61%
46,059 $4.02 Million
Q1 2020

May 14, 2020

BUY
$70.67 - $99.01 $536,243 - $751,287
7,588 Added 27.68%
34,997 $2.89 Million
Q4 2019

Feb 13, 2020

BUY
$84.35 - $95.37 $431,787 - $488,199
5,119 Added 22.97%
27,409 $2.6 Million
Q3 2019

Nov 13, 2019

BUY
$85.54 - $94.26 $9,238 - $10,180
108 Added 0.49%
22,290 $1.94 Million
Q2 2019

Aug 13, 2019

BUY
$75.4 - $92.8 $11,310 - $13,920
150 Added 0.68%
22,182 $2.03 Million
Q1 2019

May 13, 2019

BUY
$75.32 - $86.15 $1.32 Million - $1.51 Million
17,474 Added 383.37%
22,032 $2.12 Million
Q4 2018

Feb 13, 2019

SELL
$73.66 - $82.02 $43,385 - $48,309
-589 Reduced 11.44%
4,558 $391,000
Q3 2018

Nov 14, 2018

BUY
$66.94 - $77.43 $10,710 - $12,388
160 Added 3.21%
5,147 $443,000
Q1 2018

May 14, 2018

BUY
$70.39 - $84.15 $8,306 - $9,929
118 Added 2.42%
4,987 $403,000
Q4 2017

Feb 14, 2018

BUY
$72.33 - $77.64 $352,174 - $378,029
4,869
4,869 $409,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $212B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Strategic Global Advisors, LLC Portfolio

Follow Strategic Global Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Global Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Strategic Global Advisors, LLC with notifications on news.